Intravitreal Bevacizumab in Refractory Neovascular Glaucoma
نویسندگان
چکیده
منابع مشابه
Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of cases. Mediators that induce new vessel formation such as the vascular endothelial growth factor-A seem to play a key role in the pathophysiology of this condition. Herein, we report 2 cases with neovascular glaucoma secondary to ischemic central retinal vein occlusion w...
متن کاملintravitreal bevacizumab in neovascular glaucoma; a randomized clinical trial
purpose: to determine the effect of intravitreal bevacizumab (ivb) on neovascular glaucoma (nvg) in terms of intraocular pressure (iop), iris neovascularization (nvi) and best-corrected visual acuity (bcva). methods: in this randomized controlled trial, 26 eyes of 26 patients with nvg receiving conventional treatment were randomly allocated to three 2.5 mg ivb injections at 4-week intervals or ...
متن کاملIntravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
OBJECTIVE To examine the efficacy of intravitreal bevacizumab for pain relief in eyes with refractory neovascular glaucoma. METHODS In this prospective case series, 52 eyes with neovascular glaucoma were administered intravitreal bevacizumab, 1.25 mg, and monitored for 6 months. The primary outcome measure was change in subjective pain score. Intraocular pressure and iris neovascularization w...
متن کاملIntravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
PURPOSE To report a case of neovascular glaucoma due to central retinal artery occlusion treated with a single intravitreal injection of bevacizumab. METHODS A 68-year-old patient with a 10-week history of central retinal artery occlusion presented with neovascularization of the iris and the angle and intraocular pressure of 30 mm Hg. The patient received a single injection of 1.25 mg bevaciz...
متن کاملIntravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma
Purpose To report a case of refractory glaucoma secondary to iris metastasis from breast cancer which was successfully treated with intravitreal bevacizumab. Observations A 72-year-old woman presented with left ocular pain, vision loss and neovascular glaucoma secondary to iris metastasis from breast cancer. A single intravitreal injection of bevacizumab resulted in prolonged resolution of ir...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Ophthalmology
سال: 2011
ISSN: 0003-9950
DOI: 10.1001/archophthalmol.2010.350